PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 50 filers reported holding PROQR THRAPEUTICS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,129 | -19.7% | 3,945 | 0.0% | 0.00% | – |
| Q2 2023 | $6,391 | -40.2% | 3,945 | -21.4% | 0.00% | – |
| Q1 2023 | $10,693 | -82.2% | 5,020 | -69.2% | 0.00% | – |
| Q4 2022 | $60,240 | -83.8% | 16,281 | -96.7% | 0.00% | – |
| Q3 2022 | $373,000 | -6.8% | 499,679 | -2.7% | 0.00% | – |
| Q2 2022 | $400,000 | -16.1% | 513,671 | -2.6% | 0.00% | – |
| Q1 2022 | $477,000 | -87.8% | 527,396 | +8.1% | 0.00% | – |
| Q4 2021 | $3,908,000 | +758.9% | 487,914 | +796.4% | 0.00% | – |
| Q3 2021 | $455,000 | +125.2% | 54,429 | +81.2% | 0.00% | – |
| Q2 2021 | $202,000 | +1583.3% | 30,033 | +1482.3% | 0.00% | – |
| Q1 2021 | $12,000 | -88.6% | 1,898 | -92.4% | 0.00% | – |
| Q4 2020 | $105,000 | -95.5% | 24,973 | -94.8% | 0.00% | – |
| Q3 2020 | $2,315,000 | -27.8% | 483,206 | -8.3% | 0.00% | – |
| Q2 2020 | $3,205,000 | +33.5% | 527,109 | +20.6% | 0.00% | – |
| Q1 2020 | $2,400,000 | -48.0% | 437,070 | -6.1% | 0.00% | – |
| Q4 2019 | $4,614,000 | +0.4% | 465,562 | -41.7% | 0.00% | – |
| Q3 2019 | $4,597,000 | -37.2% | 798,128 | -0.8% | 0.00% | – |
| Q2 2019 | $7,321,000 | -33.0% | 804,478 | +2.2% | 0.00% | – |
| Q1 2019 | $10,919,000 | -1.3% | 787,244 | +12.3% | 0.00% | -100.0% |
| Q4 2018 | $11,064,000 | – | 701,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |